close

LATEST POSTS from Anne-Lise Berthier

Trend Chart on Microbiota – January 16, 2019

FEATURE STORY ●  AllergoOncology: microbiota in allergy and cancer - an EAACI position paper BASIC SCIENCE ● The 1000IBD project: multi-omics data of 1000 inflammatory bowel disease patients ● Effect of the nursing mother on the gut microbiome of the offspring during early mouse development ● Enhancement of the gut barrier integrity by…..

BRIEFING ON RNA TRIALS – JANUARY 2019

BioPharmAnalyses is proud to announce the launch  of the first issue of its  "BRIEFING ON RNA TRIALS" This 86-page document provides you an accurate overview to explore the latest trials in the RNA therapeutics area.    « BRIEFING ON RNA TRIALS » gives you a breakdown of trials: • by…..

EMA’s Regulatory Science to 2025 Strategy

The European Medicine Agency (EMA) is launching a six-month public consultation on its draft ‘ Regulatory Science to 2025’ strategy  for a six-month public consultation. This  sixty-page document proposes the plan for advancing the Agency’s engagement with regulatory science over the next five to ten years, covering both human and veterinary medicines. The…..

Nanocarrier-delivered microRNA to fight sepsis

Sepsis is an overreaction of the body's immune system to an infection. Cytokines flood the bloodstream in an attempt to fight the infection but also cause blood vessels to become leaky. White blood cells escape from the vessels, causing inflammation and damage to surrounding tissue, ultimately leading to multi-organ failure…..

44 cell and gene therapy products approved in the world

The International Society for Cell and Gene Therapy (ISCT), the global professional society of clinicians, researchers, regulatory specialists, technologists and industry partners in the cell and gene therapy sector, has published its first annual report detailing global cell and gene therapies (CGT) with market authorization. This report is intended to provide…..